HomeTVTX • NASDAQ
add
Travere Therapeutics Inc
Previous close
$25.00
Day range
$23.20 - $24.82
Year range
$12.57 - $28.69
Market cap
2.09B USD
Avg Volume
2.33M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 114.45M | 111.49% |
Operating expense | 76.22M | 17.66% |
Net income | -12.76M | 81.88% |
Net profit margin | -11.14 | 91.44% |
Earnings per share | 0.13 | 120.00% |
EBITDA | 1.37M | 102.41% |
Effective tax rate | -0.16% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 319.54M | -1.80% |
Total assets | 555.31M | 0.76% |
Total liabilities | 522.56M | -2.50% |
Total equity | 32.75M | — |
Shares outstanding | 89.14M | — |
Price to book | 67.57 | — |
Return on assets | -5.73% | — |
Return on capital | -7.31% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -12.76M | 81.88% |
Cash from operations | 4.98M | 112.38% |
Cash from investing | 4.85M | -83.05% |
Cash from financing | 1.48M | 88.62% |
Net change in cash | 13.26M | 220.96% |
Free cash flow | 1.43M | 100.91% |
About
Founded
2008
Website
Employees
385
